Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NEULAND LABS BIOCON NEULAND LABS/
BIOCON
 
P/E (TTM) x 25.4 19.7 129.1% View Chart
P/BV x 8.1 1.8 449.8% View Chart
Dividend Yield % 0.2 0.6 28.0%  

Financials

 NEULAND LABS   BIOCON
EQUITY SHARE DATA
    NEULAND LABS
Mar-23
BIOCON
Mar-23
NEULAND LABS/
BIOCON
5-Yr Chart
Click to enlarge
High Rs2,004388 516.8%   
Low Rs966192 504.1%   
Sales per share (Unadj.) Rs928.493.1 997.6%  
Earnings per share (Unadj.) Rs127.45.4 2,379.7%  
Cash flow per share (Unadj.) Rs168.614.6 1,152.6%  
Dividends per share (Unadj.) Rs10.001.50 666.7%  
Avg Dividend yield %0.70.5 130.1%  
Book value per share (Unadj.) Rs774.8146.5 528.8%  
Shares outstanding (eoy) m12.831,200.60 1.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.63.1 51.4%   
Avg P/E ratio x11.754.1 21.5%  
P/CF ratio (eoy) x8.819.8 44.5%  
Price / Book Value ratio x1.92.0 96.9%  
Dividend payout %7.828.0 28.0%   
Avg Mkt Cap Rs m19,052347,814 5.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,01821,810 9.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,912111,742 10.7%  
Other income Rs m977,681 1.3%   
Total revenues Rs m12,009119,423 10.1%   
Gross profit Rs m2,71816,611 16.4%  
Depreciation Rs m52811,131 4.7%   
Interest Rs m1314,190 3.1%   
Profit before tax Rs m2,1578,971 24.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5222,541 20.6%   
Profit after tax Rs m1,6356,430 25.4%  
Gross profit margin %22.814.9 153.5%  
Effective tax rate %24.228.3 85.5%   
Net profit margin %13.75.8 238.6%  
BALANCE SHEET DATA
Current assets Rs m7,609123,340 6.2%   
Current liabilities Rs m4,39085,107 5.2%   
Net working cap to sales %27.034.2 79.0%  
Current ratio x1.71.4 119.6%  
Inventory Days Days6129 4.9%  
Debtors Days Days1,109117 949.7%  
Net fixed assets Rs m8,189394,078 2.1%   
Share capital Rs m1296,003 2.1%   
"Free" reserves Rs m9,812169,926 5.8%   
Net worth Rs m9,941175,929 5.7%   
Long term debt Rs m742152,905 0.5%   
Total assets Rs m15,798517,418 3.1%  
Interest coverage x17.53.1 557.5%   
Debt to equity ratio x0.10.9 8.6%  
Sales to assets ratio x0.80.2 349.2%   
Return on assets %11.22.1 544.6%  
Return on equity %16.43.7 450.1%  
Return on capital %21.44.0 535.1%  
Exports to sales %73.53.1 2,367.5%   
Imports to sales %15.16.0 254.3%   
Exports (fob) Rs m8,7503,467 252.4%   
Imports (cif) Rs m1,8046,654 27.1%   
Fx inflow Rs m8,7503,467 252.4%   
Fx outflow Rs m1,8046,654 27.1%   
Net fx Rs m6,946-3,187 -217.9%   
CASH FLOW
From Operations Rs m2,37218,525 12.8%  
From Investments Rs m-615-142,818 0.4%  
From Financial Activity Rs m-1,358130,487 -1.0%  
Net Cashflow Rs m4036,411 6.3%  

Share Holding

Indian Promoters % 32.8 40.4 81.3%  
Foreign collaborators % 0.0 20.3 -  
Indian inst/Mut Fund % 29.1 21.1 138.3%  
FIIs % 22.7 6.6 346.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 67.2 39.4 170.7%  
Shareholders   27,723 434,339 6.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NEULAND LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NEULAND LABS vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NEULAND LABS vs Biocon Share Price Performance

Period NEULAND LABS Biocon S&P BSE HEALTHCARE
1-Day -1.12% 2.92% 1.18%
1-Month -11.56% -2.53% -0.75%
1-Year 269.91% 30.52% 61.82%
3-Year CAGR 43.81% -13.55% 18.16%
5-Year CAGR 59.26% -2.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the NEULAND LABS share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of NEULAND LABS hold a 32.8% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NEULAND LABS and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, NEULAND LABS paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 7.8%.

Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.

You may visit here to review the dividend history of NEULAND LABS, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.